ID: ALA2396943

Max Phase: Preclinical

Molecular Formula: C12H13N7O

Molecular Weight: 271.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1ccc(/N=N/c2c(N)nc(N)nc2N)cc1

Standard InChI:  InChI=1S/C12H13N7O/c1-6(20)7-2-4-8(5-3-7)18-19-9-10(13)16-12(15)17-11(9)14/h2-5H,1H3,(H6,13,14,15,16,17)/b19-18+

Standard InChI Key:  ZTNPABNQGFLCGN-VHEBQXMUSA-N

Associated Targets(Human)

Growth factor receptor-bound protein 2 663 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 271.28Molecular Weight (Monoisotopic): 271.1182AlogP: 1.84#Rotatable Bonds: 3
Polar Surface Area: 145.63Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.82CX LogP: 1.39CX LogD: 1.38
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.57Np Likeness Score: -0.71

References

1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD..  (2013)  Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen.,  21  (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023]

Source